Authors: RATAIN MJ SKOOG LA OBRIEN SM COOPER N SCHILSKY RL VOGELZANG NJ GERBER M NARANG PK NICOL SJ

Citation: Mj. Ratain et al., PHASE-I STUDY OF 3'-DEAMINO-3'-(2-METHOXY-4-MORPHOLINYL)DOXORUBICIN (FCE-23762, PNU-152243) ADMINISTERED ON A DAILY X3 SCHEDULE, Annals of oncology, 8(8), 1997, pp. 807-809

Authors: FLEMING GF WAGGONER SE ROTMENSCH J SKOOG LA LANGHAUSER C

Citation: Gf. Fleming et al., PHASE-II STUDY OF 96-HR CONTINUOUS-INFUSION ETOPOSIDE AND DOXORUBICINWITH BOLUS CYCLOPHOSPHAMIDE IN REFRACTORY EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 65(1), 1997, pp. 42-45

Authors: SKOOG LA FLEMING GF WILLIAMS SF QUIET C WAGGONER SE ROTMENSCH J HERBST AL

Citation: La. Skoog et al., RESPONSE TO CISPLATIN (P), CONTINUOUS-INFUSION (CIV) 5-FLUOROURACIL (5-FU), AND LEUCOVORIN (L) (PFL) NEOADJUVANT CHEMOTHERAPY IN CARCINOMA OF THE UTERINE CERVIX, Clinical research, 42(3), 1994, pp. 10000431-10000431